NEW YORK (GenomeWeb) – RayBiotech today announced a partnership with XCellCure to develop a cardiovascular disease diagnostic kit.

The firms will co-market and co-distribute the kits worldwide with a focus initially on the research market and the longer term goal of making the technology available to the clinical diagnostics and prognostics spaces.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.